Summary
Gilead Sciences, Inc. (GILD) filed an 8-K on July 21, 2009, to report its financial results for the quarter ended June 30, 2009. The filing primarily serves to incorporate a press release announcing these results, which provides key financial and operational updates. Investors should note that the company provided both GAAP and non-GAAP financial measures, with the latter excluding various expenses such as acquisition-related costs, restructuring, amortization, and stock-based compensation. Gilead's management uses these non-GAAP measures to offer additional insight into its operating performance. The press release, as detailed in the 8-K, likely contains critical figures related to revenue, profitability, and earnings per share for the period, offering investors a snapshot of the company's performance in the second quarter of 2009. The inclusion of these results is essential for understanding Gilead's ongoing business trends, particularly in light of its strategic initiatives and product pipeline, which are vital considerations for investment decisions.
Key Highlights
- 1Gilead Sciences announced its financial results for the second quarter ended June 30, 2009, via an 8-K filing on July 21, 2009.
- 2The company provided both Generally Accepted Accounting Principles (GAAP) and non-GAAP financial information to investors.
- 3Non-GAAP financial measures exclude items such as acquisition-related transaction costs, amortization of inventory mark-up and purchased intangibles, restructuring expenses, and stock-based compensation expenses.
- 4Management believes non-GAAP information is useful for investors and internal operational, budgeting, and financial planning purposes.
- 5The filing includes a press release (Exhibit 99.1) detailing these financial results, which is the primary source of the reported information.
- 6The information presented in the 8-K and its exhibits is not deemed 'filed' for purposes of Section 18 of the Exchange Act, limiting certain liabilities.